Fig. 2 Integrative gene prioritization. Autosomal genome-wide significant loci labeled by prioritized gene (x-axis) with shading for each line of evidence used in the bioinformatics-driven prioritization scheme (y-axis). Genes in bold were on the gold standard list (supplemental Table 7). The 7 lines of evidence evaluated were chosen to cover different mechanisms through which genetic variants contribute to disease risk, for example, regulatory changes vs protein perturbations. For VPS13D;DHRS3, F7;F10, and LINC02375;LINC02411, the genes had equal numbers of supporting lines of evidence. LINC00656 is also known as RP4-737E23.2. rs536995174 had 1 line of evidence each for SERPING1, SLC43A3, SLC43A1, F2, OR5AK4P, and LRRC55 and was excluded from this visualization. Genes with asterisks were selected for follow-up in a functional assay in zebrafish (Figure 3).
Image
Figure Caption
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Blood Adv